Results 51 to 60 of about 50,884 (170)

Innovations in Gastric Cancer Surgery During Early Minimally Invasive Era and Future Perspectives

Annals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1382-1387, September 2026.
With continuing revelations in tumor biology and the emergence of artificial intelligence, new horizons for surgical innovation are opening. At the center of this transformative journey stands the innovative surgeon, driven by passion, guided by data, and steadfast in the commitment to patient safety and quality of life.
Reut El‐On, Young‐Woo Kim
wiley   +1 more source

Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose [PDF]

, 2017
Objective: Oral iron substitution has shown to be insufficient for treatment of severe iron deficiency anemia in pregnancy. Ferric carboxymaltose is a new intravenous (i.v.) iron formulation promising to be more effective and as safe as iron sucrose.
Studer, Hanna, Irion, Olivier, De Tejada, Begoña Martinez, Schuller, Christine, Christoph, Patricia, Surbek, Daniel   +5 more
core  

Inherited microcytic anemias due to disorders of iron and heme metabolism: An updated clinical review

HemaSphere, Volume 10, Issue 9, September 2026.
Abstract Microcytic anemia is among the most common hematological abnormalities in clinical practice and is usually attributable to iron deficiency, thalassemia traits, or anemia of inflammation. A small but clinically important subset of patients, however, has inherited disorders of iron metabolism or heme synthesis presenting with persistent ...
Alexandros Makis, Ioanna Saougou, Eleftheria Hatzimichael   +2 more
wiley   +1 more source

Prehabilitation Prior to Colorectal Cancer Surgery: Impact and Implementation

Journal of Surgical Oncology, Volume 134, Issue 3, Page 434-443, September 2026.
ABSTRACT Background and Objectives Multimodal prehabilitation aims to improve surgical outcomes and preoperative fitness in patients undergoing surgery for colorectal cancer (CRC). This study evaluated implementation of a standardised prehabilitation programme for elective CRC surgery, assess its impact, and identify pitfalls and challenges during ...
Elize W. Lockhorst, Theresia A. M. Backhuijs, Teun M. E. Kerkhoff, Robert R. J. Coebergh van den Braak, Ninos Ayez, Cornelis Verhoef, Paul D. Gobardhan, Jennifer M. J. Schreinemakers   +7 more
wiley   +1 more source

A Comparative Study of IV Ferric Carboxymaltose Versus Iron Sucrose in Treatment of Iron Deficiency Anemia in Pregnancy [PDF]

, 2023
Background: To compare Intravenous Iron Sucrose Compound (ISC) with intravenous Ferric Carboxymaltose (FCM) in terms of efficacy as well as safety for treating iron deficient anaemia in pregnant patients.
Keya Patel, Archana Rokade, Ashish Kalburgi
core   +1 more source

Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia

The Egyptian Journal of Internal Medicine
Both denosumab-induced hypocalcemia and ferric carboxymaltose infusion-related hypophosphatemia have been extensively documented. There are significant risks associated with combining ferric carboxymaltose parenteral infusions and denosumab, including ...
Aysun Seker, Nurdan Senturk Durmus
doaj   +1 more source

Mechanistic Insights Into Hepatotoxicity‐Induced Liver Cirrhosis and Anemia: Iron Dysregulation, the Hepcidin–Ferroportin Axis, and Emerging Therapeutic Strategies

Organ Medicine, Volume 3, Issue 3, Page 171-185, September 2026.
Patients with alcohol‐associated liver cirrhosis or acetaminophen (APAP) toxicity frequently develop anemia with iron metabolism disturbances. Dysregulation of hepcidin–ferroportin signaling, along with inflammation, oxidative stress, hypoxia, impaired intestinal iron absorption, malnutrition, and gastrointestinal bleeding, contributes to anemia ...
Debabrata Dash, Raj Kumar Koiri
wiley   +1 more source

Variation in antenatal anaemia guidelines across the NHS in the United Kingdom: A cross‐sectional study

British Journal of Haematology, Volume 209, Issue 3, Page 1301-1310, September 2026.
Summary Antenatal anaemia affects up to 30% of pregnant women in the United Kingdom and is a recognised clinical priority. National management guidance is published by the British Society of Haematology (BSH), but the extent to which local National Health Service (NHS) guidelines align with it is unknown.
Sarah Haynes, Islam Balboula, Peter Collins, William Parry‐Smith, Haddy Fye, Amy Elsmore, Rachel Collis, Lucy De Lloyd, David Churchill, Sarah F. Bell, Simon J. Stanworth   +10 more
wiley   +1 more source

Major hematologic parameters pre- and post-ferric carboxymaltose infusion.

, 2015
Values are expressed as mean (standard deviation). P-values were calculated using the Wilcoxon Signed Rank test.Major hematologic parameters pre- and post-ferric carboxymaltose infusion.
Ernesto Cortés (744709), Maia Boscá (744708), Joaquín Borrás-Blasco (744706), Xavier Cortes (744705), Jose Ramón Molés (744707)   +4 more
core   +1 more source

Evaluation of efficacy of injection ferric carboxymaltose in pregnant women [PDF]

, 2020
Background: Iron deficiency anaemia (IDA) continues to be a very common problem in developing countries leading to a spectrum of adverse events in pregnant women.
Wani, Reena J., Sabale, Rupali M., Jalvee, Rashmi   +2 more
core   +1 more source